Mirtazapine (Remeron).
What It Does, Side Effects, and Who It Actually Helps.
Mirtazapine -- sold under the brand name Remeron -- is an antidepressant that works through a completely different mechanism than SSRIs or SNRIs. It does not block serotonin reuptake at all. Instead, it works by blocking certain receptors that normally limit how much serotonin and norepinephrine the brain releases. The result is a medication with a distinct clinical profile: sedating, appetite-stimulating, no sexual side effects, and sometimes effective when SSRIs have not worked.
It is not a first-line antidepressant for most patients, but for the right clinical picture it can be exactly the right tool.
This article is for informational purposes only and does not replace a conversation with your prescriber. Medication decisions should always be made with a licensed provider who knows your full history.
What Is Mirtazapine?
Mirtazapine is classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). Its primary action is blocking alpha-2 adrenergic receptors (which normally act as a brake on norepinephrine and serotonin release) and certain serotonin receptors (5-HT2 and 5-HT3). The net effect is increased norepinephrine and serotonin activity, achieved indirectly rather than by blocking reuptake.
Mirtazapine also strongly blocks histamine receptors -- which is where the sedation and appetite stimulation come from. Histamine blockade produces sleepiness (similar to antihistamines like Benadryl) and increases appetite. These are often side effects in other contexts, but in the right patient they are therapeutic targets.
FDA-approved for major depressive disorder. Widely used off-label for insomnia, anxiety, nausea, and appetite stimulation in cancer or eating disorder patients.
FDA Boxed Warning: Suicidal Thoughts and Behaviors
Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies of major depressive disorder and other psychiatric conditions. Short-term studies did not show this increased risk in adults over 24, and in adults 65 and older the risk was lower on an antidepressant than on placebo.
Depression itself carries a risk of suicide, which is part of why treatment matters. Anyone starting an antidepressant at any age should be monitored closely for worsening mood, agitation, or emerging suicidal thoughts, particularly in the first few months and whenever the dose changes. Families and caregivers should be told what to watch for and should stay in contact with the prescriber. Mirtazapine is not approved for use in children.
Rare but Serious: Low White Blood Cell Count
In premarketing trials, 2 of 2,796 patients on mirtazapine developed agranulocytosis, a severe drop in the white blood cells that fight infection, and a third developed severe neutropenia. This is rare, but it is the reason the following matters: if you develop a sore throat, fever, mouth sores, or other signs of infection while taking mirtazapine, contact your prescriber promptly. Bloodwork can check your white count, and the medication should be stopped if it is low.
The Paradox of the Dose
One of the most clinically interesting -- and counterintuitive -- aspects of mirtazapine is that lower doses are often more sedating than higher doses. At 7.5 to 15 mg, the histamine-blocking effect dominates: significant sedation and appetite stimulation. At 30 to 45 mg, the norepinephrine and serotonin effects become more prominent and can partially counteract the histamine sedation, making the medication somewhat less sedating despite a higher dose.
This means:
- For sleep: 7.5 to 15 mg at bedtime is often used specifically for its sedating effect
- For depression: 30 to 45 mg is usually the therapeutic range for mood
- A patient who feels "too sleepy" at 15 mg may actually do better at 30 mg
Who Is Mirtazapine Best Suited For?
The clinical profile of mirtazapine makes it particularly useful in specific situations:
- Depression with significant insomnia: Patients who cannot sleep, who wake frequently, or who have disrupted sleep as a prominent feature of their depression can benefit significantly from the sedating effect of mirtazapine.
- Depression with poor appetite or significant weight loss: Cancer patients, patients who have lost significant weight during a depressive episode, or patients with treatment-resistant depression who have lost appetite on other medications.
- SSRI-related sexual side effects: Mirtazapine does not cause sexual dysfunction because it does not act on the serotonin pathways responsible for those effects. It is sometimes added to an SSRI specifically to counteract SSRI-induced sexual side effects while augmenting antidepressant effect (sometimes called "California Rocket Fuel" when combined with venlafaxine).
- Treatment-resistant depression: When multiple SSRIs or SNRIs have not worked adequately, mirtazapine offers a different mechanism and is sometimes more effective.
- Patients who experience significant anxiety with activating antidepressants: Because mirtazapine is not activating and is actually calming, it works well for patients who have struggled with early anxiety worsening on SSRIs.
Side Effects
- Sedation -- significant, especially at lower doses. This is the most common reason patients stop the medication if they do not need the sleep benefit.
- Weight gain -- often substantial. Mirtazapine is the antidepressant most consistently associated with weight gain, driven by increased appetite and histamine blockade. This should be a central part of the conversation before starting.
- Dry mouth
- Constipation
- Elevated cholesterol -- worth monitoring with blood work during long-term use
- Vivid dreams -- reported by some patients
Notably absent: sexual side effects and the nausea commonly seen with SSRIs and SNRIs at initiation.
Weight Gain: Being Honest About It
Mirtazapine causes more weight gain on average than any other commonly prescribed antidepressant. Studies show average weight gains of 1 to 3 kg over 6 months, but individual gains can be higher -- particularly in patients who were already prone to weight gain or at higher doses. The appetite stimulation is a feature in some patients, but for others it is a significant barrier to ongoing treatment.
If weight is a concern, this needs to be discussed openly before starting. There may be better-fitting options. If mirtazapine is the right medication for other reasons, monitoring weight and making lifestyle adjustments proactively is worth planning for. See our full breakdown: antidepressants and weight gain.
Stopping Mirtazapine
Mirtazapine generally has a more manageable discontinuation profile than venlafaxine. That said, stopping abruptly after longer-term use can cause anxiety, insomnia, and nausea. A gradual taper is still recommended. The sedation benefit also disappears on stopping, which can transiently worsen sleep before the brain readjusts.
See Also
Looking for a medication that fits your full picture?
Alice Tran, PMHNP-BC, provides medication management for depression and anxiety via telehealth and in person across Virginia. The right medication depends on your specific symptoms, history, and priorities -- not a one-size-fits-all approach.
Schedule a Consultation Learn about depression treatment →Sources
- U.S. Food and Drug Administration: Remeron (mirtazapine) prescribing information. www.accessdata.fda.gov
- U.S. National Library of Medicine, MedlinePlus: Drug Information. medlineplus.gov
- Cipriani A, et al. "Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis." The Lancet, 2018.
- National Institute of Mental Health: Depression. www.nimh.nih.gov
Medical Disclaimer
The information in this article is for educational purposes only and does not constitute medical advice. Only a licensed professional can accurately diagnose and treat psychiatric conditions.
Anh Tran (Alice), PMHNP-BC, FNP-BC
Dual Board-Certified Family and Psychiatric Nurse Practitioner
Alice is a dual board-certified PMHNP and FNP licensed in Virginia. She provides compassionate, evidence-based psychiatric care via telehealth and in person across Virginia. She is fluent in both English and Vietnamese. Learn more →